225 related articles for article (PubMed ID: 8112341)
1. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
Bubeck P; Grötzinger J; Winkler M; Köhl J; Wollmer A; Klos A; Bautsch W
Eur J Biochem; 1994 Feb; 219(3):897-904. PubMed ID: 8112341
[TBL] [Abstract][Full Text] [Related]
2. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
3. Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor.
Carney DF; Hugli TE
Protein Sci; 1993 Sep; 2(9):1391-9. PubMed ID: 8401225
[TBL] [Abstract][Full Text] [Related]
4. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W
Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370
[TBL] [Abstract][Full Text] [Related]
5. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.
Monk PN; Barker MD; Partridge LJ; Pease JE
J Biol Chem; 1995 Jul; 270(28):16625-9. PubMed ID: 7622471
[TBL] [Abstract][Full Text] [Related]
6. Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.
Chen Z; Zhang X; Gonnella NC; Pellas TC; Boyar WC; Ni F
J Biol Chem; 1998 Apr; 273(17):10411-9. PubMed ID: 9553099
[TBL] [Abstract][Full Text] [Related]
7. Mapping the ligand-binding site on the C5a receptor: arginine74 of C5a contacts aspartate282 of the C5a receptor.
Cain SA; Coughlan T; Monk PN
Biochemistry; 2001 Nov; 40(46):14047-52. PubMed ID: 11705397
[TBL] [Abstract][Full Text] [Related]
8. A selection system to study C5a-C5a-receptor interactions: phage display of a novel C5a anaphylatoxin, Fos-C5aAla27.
Hennecke M; Kola A; Baensch M; Wrede A; Klos A; Bautsch W; Köhl J
Gene; 1997 Jan; 184(2):263-72. PubMed ID: 9031638
[TBL] [Abstract][Full Text] [Related]
9. Identification of a receptor-binding region in the core segment of the human anaphylatoxin C5a.
Vlattas I; Sytwu II; Dellureficio J; Stanton J; Braunwalder AF; Galakatos N; Kramer R; Seligmann B; Sills MA; Wasvary J
J Med Chem; 1994 Aug; 37(17):2783-90. PubMed ID: 8064805
[TBL] [Abstract][Full Text] [Related]
10. Receptor activation by human C5a des Arg74 but not intact C5a is dependent on an interaction between Glu199 of the receptor and Lys68 of the ligand.
Crass T; Bautsch W; Cain SA; Pease JE; Monk PN
Biochemistry; 1999 Jul; 38(30):9712-7. PubMed ID: 10423250
[TBL] [Abstract][Full Text] [Related]
11. Functional expression of a human C5a receptor clone in Xenopus oocytes requires additional RNA.
Kroll B; Emde M; Jeromin A; Penner L; Rechkemmer G; Kretzschmar T; Klos A; Köhl J; Bautsch W
FEBS Lett; 1991 Oct; 291(2):208-10. PubMed ID: 1718782
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of an isolated helical capping box in solution by hydrophobic interactions: evidence from the NMR study of bioactive peptides from the C-terminus of human C5a anaphylatoxin.
Ni F; Carpenter KA; Ripoll DR; Sanderson SD; Hugli TE
Biopolymers; 1996 Jan; 38(1):31-41. PubMed ID: 8679942
[TBL] [Abstract][Full Text] [Related]
13. Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency.
Cui L; Carney DF; Hugli TE
Protein Sci; 1994 Aug; 3(8):1169-77. PubMed ID: 7987212
[TBL] [Abstract][Full Text] [Related]
14. Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor.
Cain SA; Woodruff TM; Taylor SM; Fairlie DP; Sanderson SD; Monk PN
Biochem Pharmacol; 2001 Jun; 61(12):1571-9. PubMed ID: 11377387
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the C5a anaphylatoxin core domain using a C5a phage library selected on differentiated U937 cells.
Kola A; Baensch M; Bautsch W; Klos A; Köhl J
Mol Immunol; 1999 Feb; 36(2):145-52. PubMed ID: 10378686
[TBL] [Abstract][Full Text] [Related]
16. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
[TBL] [Abstract][Full Text] [Related]
17. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding.
Mery L; Boulay F
J Biol Chem; 1994 Feb; 269(5):3457-63. PubMed ID: 8106386
[TBL] [Abstract][Full Text] [Related]
18. Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis.
Kola A; Baensch M; Bautsch W; Hennecke M; Klos A; Casaretto M; Köhl J
Immunotechnology; 1996 Jun; 2(2):115-26. PubMed ID: 9373320
[TBL] [Abstract][Full Text] [Related]
19. A detailed analysis of the C5a anaphylatoxin effector domain: selection of C5a phage libraries on differentiated U937 cells.
Hennecke M; Otto A; Baensch M; Kola A; Bautsch W; Klos A; Köhl J
Eur J Biochem; 1998 Feb; 252(1):36-44. PubMed ID: 9523709
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding.
Zhang X; Boyar W; Galakatos N; Gonnella NC
Protein Sci; 1997 Jan; 6(1):65-72. PubMed ID: 9007977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
